Boryung Pharmaceutical is about to expand to the Asian market with ‘Kanarb’

It is known that the Boryung Pharmaceutical’s self-developed new hypertension treatment, ‘Kanarb,’ will soon be advanced to the Asian market.

According to the industry concerned on the 12th, Boryung Pharmaceutical has decided to target a number of Asian countries, excluding China and Japan, via its partner companies occupying pharmaceutical and distribution markets in Asia, such as Philippians...